Elucidation of the function of DDX3X in innate immunity

Project Information

DDX3X FUNCTION

Grant agreement ID: 252210

Project closed

Start date 1 February 2011

End date 31 January 2013

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 159 622,80

EU contribution € 159 622,80

Coordinated by

INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH
Austria

Objective

Viral infections are among the most frequent causes of human diseases and affect most people worldwide. While some viral diseases have been successfully combated, novel viral diseases like AIDS, SARS, avian influenza A H5N1, or the swine influenza A H1N1, have emerged over the last decades. Research aiming at elucidating mechanisms of viral infection and the involved immune response is, therefore, of utmost importance in order to understand viral pathogenesis and to identify novel potential drug targets. The goal of this proposal is to define the role of the RNA helicase DDX3X in the regulation of IFN-I expression. IFN-I is a central player of innate immunity and its secretion is rapidly induced upon stimulation of various receptors of the innate immune system, known as pattern recognition receptors. The current proposal aims at generating mice that lack functional DDX3X protein in specific tissues. We will test the ability of various cell types or DDX3X mutant mice to elicit effective IFN-I responses and we will assess the susceptibility to viral infections. Finally, we will examine the effect of DDX3X in acute lung injury, the main cause of death in individuals infected with SARS or influenza virus. These experiments are designed to reveal essential in vivo functions of a novel key molecule implicated in viral infections and therefore should contribute to the understanding and molecular consequences of the cellular host response to virus infections.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

• medical and health sciences › health sciences › infectious diseases › RNA viruses

You need to log in or register to use this function

Programme(s)

• FP7-PEOPLE - Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Topic(s)

• FP7-PEOPLE-2009-IIF - Marie Curie Action: "International Incoming Fellowships"

Call for proposal

FP7-PEOPLE-2009-IIF
See other projects for this call

Funding Scheme

MC-IIF - International Incoming Fellowships (IIF)

Coordinator

INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH

• EU contribution: € 159 622,80
• Address: DR BOHRGASSE 3 ; 1030 Wien ; Austria
• Region: Ostösterreich › Wien › Wien
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Total cost: No data